Tikvah Therapeutics
Atlanta, Georgia, United States
About Tikvah Therapeutics
Tikvah Therapeutics acquires, develops and commercializes novel therapeutics addressing significant unmet medical needs relating to the central nervous system - neurology and psychiatry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $10.0M
- Last round: Series Unknown (Jul 2007)
- Website: tikvah-therapeutics.com
- Phone: +18337247376
Industries & Categories
Neuroscience
Canonical: https://fsome.com/organization/tikvah-therapeutics-2524006 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.